ESMO 2025: OncoDaily LIVE Coverage

asdfs

What Drives Science and What Guides Care? Redefining Glioma Treatment in 2025

glioma

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 influential women in oncology

ON-COLLAB Brazil - International Workshop on Oncology Research Methods

ON-COLLAB

Inside the SIOP Congress 2025 with Venkatraman Radhakrishnan

Venkatraman Radhakrishnan, SIOP, retinoblastoma, Brain tumor

AEGEAN: Radiomics and on-treatment ctDNA predict pCR and associate with EFS in resectable NSCLC

AEGEAN

AACI/CCAF Annual Meeting Highlights by Wafik S. El-Deiry

Wafik S. El-Deiry

10 Oncology Experts Join OncoDaily Medical Journal’s Editorial Team

OncoDaily Medical Journal

DYNAMIC-III Trial at ESMO 2025 Presidential: ctDNA-guided adjuvant chemotherapy in stage III colon cancer.

DYNAMIC-III

OncoCalendar

« All Events

  • This event has passed.

SE Asia Course II: Immunotherapy in Lung Cancer By IASLC

Dec 16, 2024 • 7:00 PM - 9:00 PM
SE Asia Course II: Immunotherapy in Lung Cancer By IASLC

SE Asia Course II: Immunotherapy in Lung Cancer By IASLC will be held on December 16th, 2024.

This exclusive course will offer the latest updates on lung cancer treatment in Southeast Asia, with a special focus on immunotherapy. In Series II, renowned thoracic oncology experts from the region will delve into the role of immunotherapy in revolutionizing lung cancer care. Discussions will cover crucial topics such as the integration of biomarkers for immunotherapy, the best management strategies for advanced disease, and addressing challenges like pneumonitis. Participants will have the opportunity to explore how immunotherapy is set to transform the landscape of lung cancer treatment in Southeast Asia, bringing hope for improved patient outcomes.

See the Speakers and Southeast Asia Team Below:

SE Asia Course II: Immunotherapy in Lung Cancer By IASLC

Details

Date:
Dec 16, 2024
Time:
7:00 PM - 9:00 PM
Website:
https://www.iaslc.org/node/35048

Organizer

The International Association for the Study of Lung Cancer (IASLC)
Phone
1-855-464-2752
Email
info@iaslc.org